.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2015 for an immense $43 ...
.On the heels of a phase 3 win that neglected to impress investors, Ironwood Pharmaceuticals is actu...
.Don't quit Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Accept to recently's Chutes & Ladders, our summary of considerable leadership hirings, firings a...
.Commemorating his company's upsized initial public offering (IPO), Septerna chief executive officer...
.AbbVie has returned to the resource of its antipsychotic giant Vraylar seeking yet another runaway ...
.GenSight Biologics is actually full weeks off of lacking funds. Once more. The biotech only possess...
.Monopar Therapeutics is recouping a medication coming from the dump of AstraZeneca's rare illness p...
.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts ...
.After developing a genetics therapy partnership with Dyno Therapeutics in 2020, Roche is back for a...
.Lundbeck is actually reducing the book value of its own $250 thousand Abide Rehabs buyout in reacti...
.The combination of real-world records (RWD) right into procedure expediency and also web site choic...
.At this year's Strong Biotech Summit in Boston ma, our experts overtook innovators in the biotech b...
.Merck & Co. is setting down $30 million beforehand to get Yale spinout Modifi Biosciences, a bar...
.Alpha-9 Oncology has increased a $175 thousand collection C cycle to bankroll its clinical-stage ra...
.Eye medicine producer Ocuphire Pharma is acquiring genetics therapy programmer Opus Genes in an all...
.Roche's chronic coughing plan has faltered to a halt. The drugmaker, which axed the plan after the ...
.Gilead Sciences and also Merck & Co. have actually helped their once-weekly HIV combo treatment ...
.Lykos Therapeutics might possess dropped three-quarters of its own personnel in the wake of the FDA...
.Septerna might be actually as yet to divulge "any sort of relevant scientific data," but the biotec...